Group 1 - The company,豪威集团, has announced the offering price for its H shares at HKD 104.80 per share [1] - The global offering is expected to become unconditional by January 12, 2026, at 8:00 AM Hong Kong time [1] - Trading of the H shares on the main board of the Hong Kong Stock Exchange is anticipated to commence on January 12, 2026, at 9:00 AM Hong Kong time [1]

格隆汇1月8日丨豪威集团(00501.HK)发布公告，2026年1月8日，发售价已厘定为每股H股104.80港元。 假设全球发售于2026年1月12日(星期一)上午八时正(香港时间)或之前成为无条件，预期H股将于2026年 1月12日(星期一)上午九时正(香港时间)开始在联交所主板买卖。H股将以每手100股H股为单位进行买 卖。 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司（「香港結算」）對本公 告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而 產生或因依賴該等內容而引致的任何損失承擔任何責任。 本公告不會直接或間接於或向美國（包括其領土及屬地、美國任何州及哥倫比亞特區）發佈、刊發或派發。本公告 並不構成或組成在美國境內或於任何其他司法權區購買或認購發售股份的任何要約或招攬的一部分。發售股份並 無亦不會根據1933年美國《證券法》（經不時修訂）（「美國《證券法》」）或美國任何州或其他司法權區的證券法登記。 發售股份不得在美國境內提呈發售、出售、質押或以其他方式轉讓，惟根據美國《證券法》的登記規定豁免及遵守 任何適用的州證券法除外，亦不得在美國境外向非美國人士或並非根據美國《證券法》S規例為美國人士或為其利 益而購買的人士提呈發售、出售、質押或以其他方式轉讓。將不會在美國公開發售發售股份。 豪威集成電路（集團）股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：0501） 公佈發售價 本公告僅供參考，並不構成收購、購買或認購任何證 ...

公司概览 豪威集团（以下简称"公司"）作为全球化Fabless半导体设计龙头企业，以CMOS 图像传感器（CIS）为核心产品，根据弗若斯特沙利文数据，2024年按图像传感器 解决方案收入计算，位列全球第三，市场份额达13.7%，在行业内具备显著的品牌 知名度和市场认可度。其业务覆盖智能手机、汽车、医疗、安防及新兴市场（机 器视觉、智能眼镜、端侧AI）等高增长领域，产品矩阵丰富且应用场景广泛，形 成了多元化的收入支撑体系。 公司采用Fabless业务模式，专注于半导体产品设计与销售，通过与全球领先的晶 圆代工、封装测试厂商建立长期战略合作，既规避了重资产运营的资本支出压力， 又能快速获取前沿制造技术，实现对市场需求的灵活响应。同时，公司保留核心 测试环节，内部测试设施与外部协作相结合，既保障了产品质量控制，又强化了 设计迭代能力，尤其适配汽车等对产品可靠性要求极高的市场需求。 公司业绩呈现强劲复苏态势，2024年实现收入257.07亿元，同比增长22.5%，净利 润32.79亿元，同比大幅增长501.2%；2025年上半年收入139.44亿元，净利润20.20 亿元，净利率提升至14.5%。毛利率持续优化，20 ...

Core Viewpoint - The company, OmniVision Technologies, is in the process of issuing H-shares for overseas listing on the Hong Kong Stock Exchange, with the aim to raise capital and expand its market presence [1][2][3]. Group 1: H-Share Issuance Process - The company submitted its application for H-share issuance to the Hong Kong Stock Exchange on June 27, 2025, and published the application materials on the same day [1]. - On December 9, 2025, the China Securities Regulatory Commission confirmed the company's H-share issuance filing [2]. - The listing hearing by the Hong Kong Stock Exchange took place on December 11, 2025, to review the company's application [2]. Group 2: H-Share Offering Details - The H-share prospectus was published on December 31, 2025, in compliance with applicable Hong Kong laws and regulations [3]. - The global offering consists of 45,800,000 shares, with 4,580,000 shares allocated for public offering in Hong Kong (10% of total) and 41,220,000 shares for international offering (90% of total) [4]. - The maximum offering price for the H-shares is set at HKD 104.80 per share, with the public offering expected to start on December 31, 2025, and end on January 7, 2026 [5]. Group 3: Listing Timeline - The H-shares are anticipated to be listed and commence trading on the Hong Kong Stock Exchange on January 12, 2026 [5].

Core Viewpoint - OmniVision Technologies, Inc. (referred to as "OmniVision Group") has initiated its IPO process, planning to list on the Hong Kong Stock Exchange on January 12, 2026, with a target of raising approximately HKD 4.693 billion for various strategic investments and operational purposes [3][6]. Group 1: IPO Details - OmniVision Group plans to issue 23.263 million H-shares, with 10% allocated for public offering in Hong Kong and the remaining for international placement. The offering price is set at HKD 104.8 per share, with an entry fee of HKD 10,585.69 for 100 shares [3]. - The cornerstone investors include Wildlife Willow, UBS AM Singapore, and others, collectively subscribing to USD 279.38 million [4]. Group 2: Fund Utilization - The expected net proceeds of HKD 4.693 billion will be allocated as follows: 70% for R&D in key technologies over the next 5 to 10 years, 10% for global market penetration and business expansion, approximately 10% for strategic investments or acquisitions, and about 10% for working capital and general corporate purposes [6]. Group 3: Company Background and Financials - OmniVision Group, previously known as Weir Shares, was renamed in June 2025 after acquiring three major image sensor chip design companies in 2019, establishing a business framework around sensor solutions, display solutions, and analog solutions [8][10]. - The company reported revenues of RMB 20 billion, RMB 20.984 billion, and RMB 25.707 billion for the years 2022, 2023, and 2024, respectively, with gross profits of RMB 4.741 billion, RMB 4.184 billion, and RMB 7.239 billion, indicating a gross margin of 23.7%, 19.9%, and 28.2% [11][12]. - For the first nine months of 2025, OmniVision Group achieved revenues of RMB 21.783 billion, a year-on-year increase of 15.2%, and a net profit of RMB 3.21 billion, up 35% [13]. Group 4: Leadership and Shareholding Structure - The founder of OmniVision Group, Yu Renrong, controls 33.6% of the company's shares. The executive directors include Yu Renrong, Wu Xiaodong, and others [15][21]. - As of September 30, 2025, the shareholding structure includes significant stakes held by various institutional investors, with Yu Renrong's shareholding being 27.4% [21][25].

OmniVision Integrated Circuits Group, Inc. 豪威集成電路(集團)股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 股份代號 ： 0501 全球發售 聯席保薦人、整體協調人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 UBS CICC PASCHK GF Securities 整體協調人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人 Haitong International CITIC Securities 聯席牽頭經辦人 TMS OmniVision Integrated Circuits Group, Inc. 豪威集成電路 ( 集團 ) 股份有限公司 重要提示 如 閣下對本文件任何內容有任何疑問，應尋求獨立專業意見。 OmniVision Integrated Circuits Group, Inc. 豪威集成電路（集團）股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 本文件連同附錄七「送呈公司註冊處處長及展示文件」所述文件，已按照香港法例第32章《公司（清盤及雜項條 文）條例》第342C條的規定送呈香港公司註冊處處長登記。香港證券及期貨 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」或「香港聯交所」）及香港中央結算有限公司（「香 港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或 任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 除非本公告另有界定，否則本公告所用詞彙與豪威集成電路（集團）股份有限公司（「本公司」）日期為2025年12月31 日的招股章程（「招股章程」）所界定者具有相同涵義。本公告乃承本公司董事（「董事」）會（「董事會」）之命而作出。 董事會就本公告之準確性共同及個別承擔責任。 本公告僅供參考，並不構成收購、購買或認購任何證券的邀請或要約。本公告並非招股章程。潛在投資者在決定 是否投資於發售股份前，應細閱招股章程以了解下文所述有關全球發售的詳細資料。投資者應僅依賴招股章程所 載資料作出有關發售股份的任何投資決定。 本公告不會直接或間接於或向美國（包括其領土及屬地、美國任何州及哥倫比亞特區或法律禁止此類發佈的任何 其他司法權區）發佈、刊發或派發。本公告並不構成或組成在美國境內或於任何其他司法權區購買或認購證券的任 何要約或招攬的一部分。本公告所述證券 ...

Core Viewpoint - The announcement details the interest payment schedule for the convertible bonds issued by the company, highlighting the terms and conditions related to the bonds and their interest payments [2][11]. Group 1: Bond Issuance Overview - The company issued 24.40 billion RMB worth of convertible bonds, with a total of 24.4 million bonds at a face value of 100 RMB each [2]. - The bonds have a maturity period of six years, from December 28, 2020, to December 27, 2026 [2]. - The coupon rates for the bonds are structured to increase over the years, starting from 0.2% in the first year to 2.0% in the sixth year [2]. Group 2: Interest Payment Details - The interest payment for the fourth year will be 1.8 RMB per bond (including tax), applicable for the period from December 28, 2024, to December 27, 2025 [11][14]. - The interest payment date is set for December 29, 2025, with the record date for interest entitlement being December 26, 2025 [12][6]. - Holders who convert their bonds into shares before the record date will not receive interest for the current and future periods [3][11]. Group 3: Taxation and Regulatory Information - Individual investors are subject to a 20% tax on interest income, resulting in a net payment of 1.44 RMB per bond after tax [14]. - The bonds are rated AA+ by Shanghai New Century Credit Rating Co., Ltd. [8]. - The bonds are not secured by any collateral [9]. Group 4: Administrative and Contact Information - The bonds are managed by China Securities Depository and Clearing Corporation Limited, Shanghai Branch [10]. - The issuer's contact information includes the address and phone number for inquiries related to the bonds [15].

香港聯合交易所有限公司與證券及期貨事務監察委員會對本聆訊後資料集的內容概不負責，對其準 確性或完整性亦不發表任何意見，並明確表示概不就因本聆訊後資料集全部或任何部分內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 本聆訊後資料集為草擬本，其內所載資訊並不完整，亦可能會作出重大變動。 閣下閱覽本 文件，即代表 閣下知悉、接納並向本公司、本公司的聯席保薦人、整體協調人、顧問或承銷團成員 表示同意： 本公司招股章程根據香港法例第32章《公司（清盤及雜項條文）條例》送呈香港公司註冊處處長 註冊前，不會向香港公眾人士提出要約或邀請。倘於適當時候向香港公眾人士提出要約或邀請，有 意投資者務請僅依據於香港公司註冊處處長註冊的本公司招股章程作出投資決定；招股章程的文本 將於發售期內向公眾人士派發。 OmniVision Integrated Circuits Group, Inc. 豪威集成電路（集團）股份有限公司 （「本公司」） 39553 \ (Project Hercules_PHIP) \ 14/12/2025 \ M08 （於中華人民共和國註冊成立的股份有限公司） 的聆訊後資料集 警告 本聆訊後資料集乃根 ...